Bloomios Inc - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS

Ticker Exchange SIC # Website Latest Ticker
BLMS Over the counter 2833

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bloomios Inc

Bloomios Completes $23.5 Million Acquisition of Leading Gummy Manufacturer - Oct 27th, 2022 12:31 pm
Upexi Announces Sale of Select CBD Assets for $23.5 Million - Oct 27th, 2022 12:30 pm
Bloomios To Present at The 2022 LD Micro Main Event October 25-27 - Oct 20th, 2022 7:00 pm
Bloomios to Develop and Produce New Range of Private-Label Products Utilizing, Ashwagandha, Melatonin, Kratom, Lion's Mane, Valerian Root, Reishi Mushroom and other Natural Ingredients - Aug 4th, 2022 8:44 pm
Bloomios to Present at the 2022 LD Micro Invitational June 7-9 - May 25th, 2022 12:31 pm
Bloomios Expands Production Capacity by 300%, Setting Stage for Strong Growth in 2022 - May 18th, 2022 12:31 pm
Bloomios Reports 2021 Revenue at Record $8.5 Million, up from $1.3 Million in 2020 - Apr 19th, 2022 12:31 pm
Bloomios Selected as Exclusive Manufacturer for DRYWORLD's New Athletic Performance CBD Product Line - Mar 31st, 2022 8:40 pm
DRYWORLD Struts into Multi-Billion Dollar CBD Market - Mar 31st, 2022 8:20 pm